- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech Sustainable Track Record
Chinese Pharmaceuticals & Biotech Sustainable Track Record
Results
7
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
7 companies
WuXi AppTec
Market Cap: CN¥299.4b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥103.30
7D
9.9%
1Y
163.7%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥16.6b
Engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China.
300573
CN¥67.63
7D
1.0%
1Y
10.0%
Henan Lingrui Pharmaceutical
Market Cap: CN¥13.2b
Produces and sells medicines in China.
600285
CN¥23.43
7D
-2.9%
1Y
0.3%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥30.4b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥46.11
7D
-0.9%
1Y
60.2%
Xiamen Amoytop Biotech
Market Cap: CN¥33.8b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥83.08
7D
-2.6%
1Y
48.8%
Hunan Jiudian Pharmaceutical
Market Cap: CN¥9.2b
Researches, develops, produces, and sells pharmaceutical products in China and internationally.
300705
CN¥18.53
7D
-5.7%
1Y
-15.3%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥51.3b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥114.00
7D
25.6%
1Y
133.7%